Search For "phase 3"
Ahead of Phase 3 UP Assembly polls, potato farmers say falling prices, str
Updated : 4 years ago IST
Farukkabad (Uttar Pradesh) [India], February 18 (ANI): Ahead of the third phase of Uttar Pradesh Assembly elections, which will cover majorly cover the state's potato farming belt, potato farmers have raised their pressing issues including falling prices, stray cattle menace and high electri
Read More
COVID-19: Nasal vaccine could be a game-changer if it provides mucosal imm
Updated : 4 years, 1 month ago IST
New Delhi [India], January 30 (ANI): As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sanjay
Read More
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID boos
Updated : 4 years, 2 months ago IST
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
Read More
Biological E gets approval to conduct trials of Corbevax as booster dose
Updated : 4 years, 2 months ago IST
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Read More
Bharat Biotech seeks DCGI's approval for its intranasal COVID-19 booster d
Updated : 4 years, 2 months ago IST
New Delhi [India], December 20 (ANI): As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dose
Read More
Lancet Infectious Diseases study compare well with phase 3 clinical trials
Updated : 4 years, 3 months ago IST
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
Read More
Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID
Updated : 4 years, 4 months ago IST
Hyderabad (Telangana) [India], November 12 (ANI): Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech's Covaxin.
Read More
Pharande Spaces launches Phase 3 of iconic integrated township Puneville
Updated : 4 years, 4 months ago IST
Pune (Maharashtra) [India], October 16 (ANI/NewsVoir): Continuing the success saga of one of India's most iconic celebrated integrated townships, Pharande Spaces today announced that Phase 3 of Puneville is open for booking on the auspicious festive day Dussehra.
Read More
UP govt launches Nirbhaya-Ek Pahal programme, to benefit over 75,000 women
Updated : 4 years, 5 months ago IST
Lucknow (Uttar Pradesh) [India], September 30 (ANI): The Uttar Pradesh government on Wednesday launched the ''Nirbhaya - Ek Pahal'' programme under Mission Shakti - Phase 3 in Uttar Pradesh's Lucknow district.
Read More
Adityanth launches 'Nirbhaya - Ek Pahal' programme, over 75,000 women to b
Updated : 4 years, 5 months ago IST
Lucknow (Uttar Pradesh) [India], September 29 (ANI): The Uttar Pradesh government on Wednesday launched the 'Nirbhaya - Ek Pahal' programme under Mission Shakti - Phase 3 in Lucknow.
Read More
Sputnik Light Covid vaccine gets permission for Phase 3 trials in India
Updated : 4 years, 6 months ago IST
New Delhi [India], September 15 (ANI): The Drug Controller General of India has given its approval to the single-dose COVID-19 vaccine version of the Sputnik V vaccine 'Sputnik Light' to conduct trials on the Indian population to check whether the vaccine gives a similar immune response i
Read More
Will take another 4-5 months to publish phase 3 trials data of ZyCoV-D vac
Updated : 4 years, 6 months ago IST
New Delhi [India], August 21 (ANI): Managing Director of Zydus Group Dr Sharvil Patel on Saturday said that his firm will soon apply for the Indian drug regulator's approval to conduct trials of ZyCoV-D on children above 2 years and added that it will take another 4-5 months to publish the p
Read More